Open Biosystems' Open Access RNAi Program Continues to Gain Momentum...( University College London and Hospit...),Health

University College London and Hospital for Sick Kids purchase Open Access

to lentiviral RNAi libraries

HUNTSVILLE, Ala., March 26 /PRNewswire/ -- Open Biosystems, Inc., announced today that two leading research institutions, University College London (UCL), U.K., and the Hospital for Sick Kids, Toronto, Canada, have recently purchased access to Open Biosystems' shRNAmir technologies for RNAi by joining the Open Access RNAi(TM) Program.

(Logo: http://www.newscom.com/cgi-bin/prnh/20070423/CLM143LOGO )

The Open Access Program, unique in this field, supports Open Biosystems' vision of supporting basic and medical research and reinforces its commitment to expanding access to research reagents for the life sciences community.

Both institutions purchased access to Open Biosystems' lentiviral shRNAmir libraries developed in collaboration with Drs Greg Hannon and Steve Elledge and exclusively distributed through Open Biosystems.

"Functional genomics is playing an ever important role in deciphering the roles of specific genes in cancer and developmental biology, as well as in neuro-sciences, infectious diseases and immunity. Open Biosystems' Open Access RNAi program helped foster this collaboration between the UCL Cancer Institute (hosting the new RNAi facility), UCL Institutes for Child Health and Neurology, and Division of Infection and Immunity, enabling us to provide world-class scientists in central London access to the latest shRNA libraries for focused functional screens, as well as stable knock-down experiments for pre-clinical models." said Dr. Chris Boshoff, Director, UCL Cancer Institute, http://www.ucl.ac.uk/cancer

"Gene silencing using RNAi is gaining popularity around the world as researchers realize and witness its value both for understanding gene func
'/>"/>